Evidence map›Paper›PMID 27126912›Full record

ArticleScientific reports2016

Genotypic Prediction of Co-receptor Tropism of HIV-1 Subtypes A and C.

Mona Riemenschneider, Kieran Y Cashin, Bettina Budeus, Saleta Sierra, Elham Shirvani-Dastgerdi, Saeed Bayanolhagh, Rolf Kaiser, Paul R Gorry, Dominik Heider

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Next generation sequencing reveals a high frequency of CXCR4 utilizing viruses in HIV-1 chronically infected drug experienced individuals in South Africa.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2018
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 3 countries.

Mona RiemenschneiderDepartment of Bioinformatics, Straubing Center of Science, University of Applied Sciences Weihenstephan-Triesdorf, Straubing, Germany.
Kieran Y CashinCenter for Biomedical Research, Burnet Institute, Melbourne, Australia.
Bettina BudeusDepartment of Bioinformatics, University of Duisburg-Essen, Essen, Germany.
Saleta SierraInstitute of Virology, University of Cologne, Cologne, Germany.
Elham Shirvani-DastgerdiViral Hepatitis and Immunobiology Lab, University Hospital Aachen, Aachen, Germany.
Saeed BayanolhaghIranian Research Center of HIV /AIDS, Tehran University of Medical Sciences, Tehran, Iran.
Rolf KaiserInstitute of Virology, University of Cologne, Cologne, Germany.
Paul R GorryCenter for Biomedical Research, Burnet Institute, Melbourne, Australia.
Dominik HeiderDepartment of Bioinformatics, Straubing Center of Science, University of Applied Sciences Weihenstephan-Triesdorf, Straubing, Germany.
University of Cologne · DEWeihenstephan-Triesdorf University of Applied Sciences · DEBurnet Institute · AURMIT University · AUTehran University of Medical Sciences · IRUniversitätsklinikum Aachen · DEUniversity of Duisburg-Essen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antiretroviral treatment of Human Immunodeficiency Virus type-1 (HIV-1) infections with CCR5-antagonists requires the co-receptor usage prediction of viral strains. Currently available tools are mostly designed based on subtype B strains and thus are in general not applicable to non-B subtypes. However, HIV-1 infections caused by subtype B only account for approximately 11% of infections worldwide. We evaluated the performance of several sequence-based algorithms for co-receptor usage prediction employed on subtype A V3 sequences including circulating recombinant forms (CRFs) and subtype C strains. We further analysed sequence profiles of gp120 regions of subtype A, B and C to explore functional relationships to entry phenotypes. Our analyses clearly demonstrate that state-of-the-art algorithms are not useful for predicting co-receptor tropism of subtype A and its CRFs. Sequence profile analysis of gp120 revealed molecular variability in subtype A viruses. Especially, the V2 loop region could be associated with co-receptor tropism, which might indicate a unique pattern that determines co-receptor tropism in subtype A strains compared to subtype B and C strains. Thus, our study demonstrates that there is a need for the development of novel algorithms facilitating tropism prediction of HIV-1 subtype A to improve effective antiretroviral treatment in patients.

Indexed as

GenotypeViral TropismComputational BiologyGenotyping TechniquesHIV-1HIV Envelope Protein gp120Humansgp120 protein, Human immunodeficiency virus 1HIV Envelope Protein gp120

Identifiers

PMID27126912
PMCPMC4850382
OpenAlexW2344221688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.